Company / Operating Cash Flow
SOLENO THERAPEUTICS INC Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$46.8M
FY2025
5-year range
-$69.1M / $46.8M
FY2021-FY2025
Trend
+167.7%
vs FY2024
Sector context
#62 of 214
Health Care
What the data says
At $47M, SOLENO THERAPEUTICS INC's operating cash flow ranks #62 of 214 in the Health Care sector. Operating Cash Flow returned to growth in FY2025 after 2 years of decline, reaching $47M.
Based on SEC 10-K filings.
$47M in FY2025.
Improved from -$25M to $47M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#62 of 214 in Health CareTop 29% of 214This company $46.8M Sector average $663.6M
▼
-92.9% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow increased 167.7% year-over-year.
- Ranks #62 out of 214 companies in the Health Care sector.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $46.8M | +167.7% |
| FY2024 | -$69.1M | -177.0% |
| FY2023 | -$24.9M | -20.0% |
| FY2022 | -$20.8M | +25.2% |
| FY2021 | -$27.8M | -10.1% |
| FY2020 | -$25.2M | -45.2% |
| FY2019 | -$17.4M | -48.7% |
| FY2018 | -$11.7M | -17.4% |
| FY2017 | -$9.9M | +26.3% |
| FY2016 | -$13.5M | -31.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026